Wang Chunguo, Wu Sikai, Zhang Rongwei, Jin Ke, Qian Yicheng, Mao Ning, Liu Yun, Zhang Miao, Zhang Ke, Wang Renfeng, Huang Gang, Zhang Min, Chen Baofu, Shen Jianfei
Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China.
Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Front Surg. 2021 Jul 8;8:637441. doi: 10.3389/fsurg.2021.637441. eCollection 2021.
In 1995, a clinical randomized controlled study (RCT) conducted by the Lung Cancer Study Group (LCSG) pointed out that the lobectomy was the gold standard for treating early lung cancer. However, with the development of technology, the results of several retrospective studies have shown that the efficacy of pulmonary segmentectomy is equivalent to that of lobectomy. Currently, it is still controversial whether segmental resection or lobectomy should be performed for early lung cancer. Thus, we aim to summarize the indications of segmentectomy. To conduct the review, previous researches involving indications of segmentectomy were collected from the literature using Pubmed. These articles were published and accepted in English in the medical literature from 2013 to 2020. We have focused on segmentectomy and its indications. A total of 176 articles were retrieved from the Pubmed database, of which 31 articles included indications for segmentectomy. We summarized the relevant content, and the potential and prospect of segmentectomy for the treatment of lung cancer were emphasized. These findings have a number of important implications for future practice. Pulmonary segmentectomy is a very vital surgical procedure for select patients with lung cancer, which provides a novel approach for the treatment of lung cancer and the survival of lung cancer patients.
1995年，肺癌研究组（LCSG）进行的一项临床随机对照研究（RCT）指出，肺叶切除术是治疗早期肺癌的金标准。然而，随着技术的发展，多项回顾性研究结果表明，肺段切除术的疗效与肺叶切除术相当。目前，早期肺癌应行肺段切除术还是肺叶切除术仍存在争议。因此，我们旨在总结肺段切除术的适应证。为进行本综述，我们通过Pubmed从文献中收集了此前涉及肺段切除术适应证的研究。这些文章于2013年至2020年期间在医学文献中以英文发表并被接受。我们重点关注肺段切除术及其适应证。从Pubmed数据库中共检索到176篇文章，其中31篇文章包含肺段切除术的适应证。我们总结了相关内容，并强调了肺段切除术治疗肺癌的潜力和前景。这些发现对未来的实践有许多重要意义。肺段切除术对于部分肺癌患者而言是一项非常重要的外科手术，它为肺癌治疗及肺癌患者的生存提供了一种新方法。
